ASX:AYAHealth Care Equipment & ServicesHealth Care Technology
ARTRYA ORD
$4.390
$0.110 (2.44%)
Day Range
$4.390 - $4.670
52 Week Range
$0.605 - $5.240
Volume
428.14K
Avg Volume (10D)
374.61K
Market Cap
$701.52M
Price Chart
Market Statistics
Open$4.460
Previous Close$4.500
Day High$4.670
Day Low$4.390
52 Week High$5.240
52 Week Low$0.605
Valuation
Market Cap701.52M
Shares Outstanding159.80M
Price to Book7.87
Trading Activity
Volume428.14K
Value Traded1.94M
Bid$4.390 × 227
Ask$4.540 × 1,000
Performance
1 Day9.61%
5 Day9.07%
13 Week25.00%
52 Week569.17%
YTD-5.52%
Technical Indicators
RSI (14)60.39
50-Day SMA$3.538
200-Day SMA$3.100
Latest News
Biotechnology
Artrya Secures Second US Commercial Order for Salix SaaS Platform to Manage Coronary Artery Disease
Artrya (ASX: AYA) has signed a commercial agreement with US-based Northeast Georgia Health System for the use of its Salix AI cloud platform for point-of-care assessment and management of coronary artery disease.
1 min read
Biotechnology
Artrya Wins FDA Clearance to Advance Rollout of Salix Coronary Plaque Module
Artrya (ASX: AYA) has received clearance from the US Food and Drug Administration for its Salix Coronary Plaque module. The regulatory milestone enables the company to charge per-scan fees in its largest market, significantly enhancing revenue potential. The approval follows Artrya’s recent US launch and builds on momentum established with its Salix Coronary Anatomy platform. […]
3 min read
